AIM
MIRM icon

Aigen Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Aigen Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,349
Closed -$539K – 844
2025
Q3 		$539K Buy
7,349
+845
+13% +$53.7K 0.08% 378
2025
Q2 		$331K Sell
6,504
-3,425
-34% -$152K 0.05% 499
2025
Q1 		$447K Buy
9,929
+2,187
+28% +$103K 0.07% 378
2024
Q4 		$320K Buy
+7,742
New +$323K 0.06% 457

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aigen Investment Management's MIRM Position: Q4 2025 in Review

Aigen Investment Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 7,349 shares — an estimated $539K sold.

Aigen Investment Management first reported a position in MIRM in Q4 2024 and held it in 4 quarters. The position peaked at $539K in Q3 2025. 282 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Aigen Investment Management reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 7,349 Mirum Pharmaceuticals shares in Q4 2025, an estimated $539K.
  • Aigen Investment Management first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Aigen Investment Management's Mirum Pharmaceuticals position peaked at $539K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.